Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Vaccine delivery joint venture finalized by Endorex and Elan

Jan. 28, 1998

Phytochemistry alliance formed by Xenova Discovery and IGER

Jan. 27, 1998

Lilly and Allelix expand research programs

Jan. 27, 1998

New HIV-based gene delivery system pioneered at Oxford BioMedica

Jan. 22, 1998

Genetronics to begin phase II head and neck cancer trial in Canada

Jan. 22, 1998

T Cell Sciences and Walter Reed collaborate on inhibition of liposome-induced complement activation

Jan. 22, 1998

Repligen and Glaxo extend Glyceptor collaboration

Jan. 22, 1998

Dynavax and Vical crosslicense DNA immunization technology

Jan. 21, 1998

Ribozyme, Parke-Davis intend to collaborate

Jan. 20, 1998

Pharmacopeia achieves milestone in collaboration with Daiichi

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...